Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections

Modern Pathology

Volumn 11, Issue 8, 1998, Pages 740-746

  Kaufmann, Olaf ^a   Koch, Stefan ^b   Burghardt, Jens ^a   Audring, Heike ^a   Dietel, Manfred ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institute of Pathology   (Germany)

Author keywords

Immunohistochemistry; KBA62; Melan A; Melanomas; Tyrosinase

Indexed keywords

CYTOKERATIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HMB 45; MONOPHENOL MONOOXYGENASE; PARAFFIN; PROTEIN S 100; TUMOR MARKER;

ADRENAL CORTEX CARCINOMA; AMELANOTIC MELANOMA; ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LEYDIG CELL TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MELANOCYTE; METASTASIS; MYELOMA; PRIORITY JOURNAL; SARCOMA; TISSUE SECTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MELANOMA, AMELANOTIC; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; PARAFFIN; S100 PROTEINS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL;

EID: 0031828012     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional lymph nodes: analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg 1991;214:491-9.
2. Nakhleh RE, Wick MR, Rocamora A, Swanson PE, Dehner LP. Morphologic diversity in malignant melanomas. Am J Clin Pathol 1990;93:731-40.
3. Prieto VG, Kanik A, Salob S, McNutt NS. Primary cutaneous myxoid melanoma: immunohistologic clues to a difficult diagnosis. J Am Acad Dermatol 1994;30:335-9.
4. Sheibani K, Battifora H. Signet-ring cell melanoma: a rare morphologic variant of malignant melanoma. Am J Surg Pathol 1988;12:28-34.
5. Mowat A, Reid R, Mackie R. Balloon cell metastatic melanoma: an important differential in the diagnosis of clear cell tumors. Histopathology 1994;24:469-72.
6. Mourad WA, Mackay B, Ordonez NG, Ro JY, Swanson DA. Clear cell melanoma of the bladder. Ultrastruct Pathol 1993; 17:463-8.
7. Chang ES, Wick MR, Swanson PE, Dehner LP. Metastatic malignant melanoma with "rhabdoid" features. Am J Clin Pathol 1994;102:426-31.
8. Bhuta S, Mirra JM, Cochran AJ. Myxoid malignant melanoma: a previously undescribed histologic pattern noted in metastatic lesion. A report of four cases. Am J Surg Pathol 1986;10:203-11.
9. Lodding P, Kindblom LG, Angervall L. Metastases of malignant melanomas simulating soft tissue sarcoma: a clinicopathological, light-, and electron microscopic and immunohistochemical study of 21 cases. Virchows Arch A Pathol Anat Histopathol 1990;417:377-88.
10. Orchard G, Jones EW. Immunocytochemistry in the diagnosis of malignant melanoma. Br J Biomed Sci 1994;51:44-56.
11. Cohen-Knafo E, Al Saati T, Aziza J, Ralfkiaer E, Selves J, Gorguet B, et al. Production and characterization of an antimelanoma monoclonal antibody KBA.62 using a new melanoma cell line reactive on paraffin wax-embedded sections. J Clin Pathol 1995;48:826-31.
12. Wick MR, Swanson PE, Scheithauer BW, Manivel JC. Malignant peripheral nerve sheath tumor: an immunohistochemical study of 62 cases. Am J Clin Pathol 1987;87:425-33.
13. Takashi M, Haimoto H, Murase T, Mitsuya H, Kato K. An immunochemical and immunohistochemical study of S-100 protein in renal cell carcinomas. Cancer 1988;61:889-95.
14. Drier JK, Swanson PE, Cherwitz DL, Wick MR. S-100 protein immunoreactivity in poorly differentiated carcinomas: immunohistochemical comparison with malignant melanoma. Arch Pathol Lab Med 1987;111:447-52.
15. Herrera GA, Turbat-Herrera EA, Lott RL. S-100 protein expression by primary and metastatic adenocarcinomas. Am J Clin Pathol 1988;89:168-76.
16. Hashimoto H, Daimaru Y, Enjoji M. S-100 protein distribution in liposarcoma: an immunoperoxidase study with special reference to the distinction of liposarcoma from myxoid malignant fibrous histiocytoma. Virchows Arch A Pathol Anat Histopathol 1984;450:1-10.
17. Coindre JM, De Mascarel A, Trojani M, De Mascarel I, Pages A. Immunohistochemical study of rhabdomyosarcoma: unexpected staining with S-100 protein and cytokeratin. J Pathol 1988;155:127-32.
18. Wagner SN, Wagner C, Höfler H, Atkinson MJ, Goos M. Expression cloning of the cDNA encoding a melanoma-associated antigen recognized by mab HMB-45. Lab Invest 1995;73:229-35.
19. Adema GJ, De Boer AJ, van 't Hullenaar R, Denijn M, Ruiter DJ, Vogel AM, et al. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single c-DNA. Am J Pathol 1993;143:1579-85.
20. Lee ZH, Hou L, Moellmann G, Kuklinska E, Antol K, Fraser M, et al. Characterization and subcellular localization of human Pmel 17/silver, a 110-kDa (pre) melanosomal membrane protein associated with 5,6-dihydroindole-2-carboxylic acid (DHICA) converting activity. J Invest Dermatol 1996;106:605-10.
21. Bacchi CE, Bonetti F, Pea M, Martignoni G, Gown AM. HMB-45: a review. Appl Immunohistochem 1996;4:73-85.
22. Achilles E, Schröder S. Positive cytokeratin results in malignant melanoma: pitfall in differential immunohistologic diagnosis of occult neoplasms. Pathologe 1994;15:235-41.
23. Kwon BS. Pigmentation genes: the tyrosinase gene family and the Pmel 17 gene family. J Invest Dermatol 1993;100: 134S-40S.
24. Sensi M, Traversari C, Radrizzani M, Stefania S, Macalli C, Mortarini R, et al. Cytotoxic T-lymphocyte clones from different patients display limited T-cell receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen melan-A/MART-1. Proc Natl Acad Sci U S A 1995;92:5674-8.
25. Busam KJ, Iversen K, Coplan KA, Old LJ, Stockert E, Chen YT, et al. Immunoreactivity for A103, an antibody to melan-A (MART-1), in adrenocortical and other steroid tumors. Am J Surg Pathol 1998;22:57-63.
26. DeLong W, Grignon DJ, Eberwein P, Shum DT, Wyatt JK. Sarcomatoid renal cell carcinoma: an immunohistochemical study of 18 cases. Arch Pathol Lab Med 1993;117:636-40.
27. Norton AJ, Jordan S, Yeomans P. Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 1994;173:371-9.
28. Morgan JM, Navabi H, Schmid KW, Jasani B. Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J Pathol 1994;174:301-7.
29. Blessing K, Sanders DSA, Grant JJH. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology 1998;32:139-46.
30. Miller RT, Kubier P. Blocking of endogenous avidin-binding activity in immunohistochemistry: the use of egg whites. Appl Immunohistochem 1997;5:63-6.
31. Fetsch PA, Kleiner D, Marincola FM, Abati A. Analysis of melanoma-associated antigen, MART-1, in normal tissues and in selected nonmelanomatous neoplasms [abstract]. Mod Pathol 1997;10:43A.
32. Pileri S, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, et al. Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 1997;183:116-23.
33. Ben Izhak O, Stark P, Levy R, Bergman R, Lichtig C. Epithelial markers in malignant melanoma: a study of primary lesions and their metastases. Am J Dermatopathol 1994;16:241-6.